Zhicheng Yang

1.8k citations
55 papers · 1.3k indexed · h-index 19
Topics
Cytokine Signaling Pathways and Interactions (5 papers)Osteoarthritis Treatment and Mechanisms (4 papers)Inflammasome and immune disorders (4 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEScientific Reports

In The Last Decade

Zhicheng Yang

52 papers receiving 1.3k citations

Peers

Zhicheng Yang
Comparison fields: 5 of 117
  • Molecular Biology 627
  • Cancer Research 333
  • Immunology 250
  • Oncology 226
  • Pharmacology 138
Replace Yasufumi Katanasaka with:
Yasufumi Katanasaka Japan
Ying Lu China
Sheng Liu China
Gaurav Swarnkar United States
Huan Li China
Tingting Feng China
Cristina Sánchez‐de‐Diego Spain
Haigang Li China
Zhicheng Yang relative to Yasufumi Katanasaka Japan Yasufumi Katanasaka's profile →
Citations per field
00.5×1.5×
Yasufumi Katanasaka · 1×
Citations per year

Countries citing papers authored by Zhicheng Yang

Since Specialization
Citations

This map shows the geographic impact of Zhicheng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhicheng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhicheng Yang more than expected).

Fields of papers citing papers by Zhicheng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhicheng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhicheng Yang. The network helps show where Zhicheng Yang may publish in the future.

Co-authorship network of co-authors of Zhicheng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhicheng Yang. A scholar is included among the top collaborators of Zhicheng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhicheng Yang. Zhicheng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 6
4 2
5 15
6 73
7 1
8 2
9 7
10 29
11 24
12 12
13 3
14 2
15 144
16 16
17 7
18 95
19 2
20 53

About Zhicheng Yang

Zhicheng Yang is a scholar working on Otorhinolaryngology, Rheumatology and Immunology, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Cancer Research (333 citations), Immunology (250 citations) and Complementary and alternative medicine (80 citations). Zhicheng Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bing Liu, Qipeng Wu, Juan Li, Yueming Chen, Luyong Zhang, Jie Yang, Huachao Li, Yanchao Deng, Xindie Zhou and Ruiping Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026